Jung, C.; Kim, M.H.; Kim, Y.Y.; Kim, J.A.; Ko, E.J.; Lee, S.H.; Kim, D.Y.
Determining the Optimal Administration Conditions under Which MIF Exerts Neuroprotective Effects by Inducing BDNF Expression and Inhibiting Apoptosis in an In Vitro Stroke Model. Brain Sci. 2021, 11, 280.
https://doi.org/10.3390/brainsci11020280
AMA Style
Jung C, Kim MH, Kim YY, Kim JA, Ko EJ, Lee SH, Kim DY.
Determining the Optimal Administration Conditions under Which MIF Exerts Neuroprotective Effects by Inducing BDNF Expression and Inhibiting Apoptosis in an In Vitro Stroke Model. Brain Sciences. 2021; 11(2):280.
https://doi.org/10.3390/brainsci11020280
Chicago/Turabian Style
Jung, Chul, Mi Hee Kim, Ye Yeong Kim, Ji Ae Kim, Eun Jae Ko, Seung Hak Lee, and Dae Yul Kim.
2021. "Determining the Optimal Administration Conditions under Which MIF Exerts Neuroprotective Effects by Inducing BDNF Expression and Inhibiting Apoptosis in an In Vitro Stroke Model" Brain Sciences 11, no. 2: 280.
https://doi.org/10.3390/brainsci11020280
APA Style
Jung, C., Kim, M. H., Kim, Y. Y., Kim, J. A., Ko, E. J., Lee, S. H., & Kim, D. Y.
(2021). Determining the Optimal Administration Conditions under Which MIF Exerts Neuroprotective Effects by Inducing BDNF Expression and Inhibiting Apoptosis in an In Vitro Stroke Model. Brain Sciences, 11(2), 280.
https://doi.org/10.3390/brainsci11020280